Protein Tyrosine Kinase
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25079 | Sevabertinib ( BAY-2927088 ) | 2521285-05-0 | ≧98.0% |  |
| Sevabertinib ( BAY-2927088 ) is a oral, non-covalent, tyrosine kinase receptor inhibi | ||||
| 20524 | Zidesamtinib ( NVL-520 ) | 2739829-00-4 | ≧98.0% |  |
| Zidesamtinib ( NVL-520 ) is a novel brain-penetrant ROS1-selective tyrosine kinase in | ||||
| 20548 | Pimicotinib ( ABSK02 ) | 2253123-16-7 | ≧98.0% |  |
| Pimicotinib is a novel small molecule inhibitor of CSF-1R, which is orally available, | ||||
| 21238 | Seralutinib | 1619931-27-9 | 98% Min. |  |
| Seralutinib, also known as PK-10571 and GB002, is a Novel Inhaled Pdgfr Kinase Inhibi | ||||
| 17031303 | Tirabrutinib free base ( ONO-4059 ) | 1351636-18-4 | ≧98.0% | _1351636-18-4.png) |
| Tirabrutinib, also known as ONO-4059 is a potent and orally active Bruton agammaglobu | ||||
| 17012103 | Tirabrutinib HCl | 1439901-97-9 | ≧98.0% |  |
| ONO-4059 is a selective and novel inhibitor of BTK with IC50 2.2 nm, ONO-4059 binds t | ||||
| 174191 | SU5402 | 215543-92-3 | ≧98.0% |  |
| SU5402 is a fibroblast growth factor receptor (FGFR)-specific tyrosine kinase inhibit | ||||
| 24003 | NVL-655 ( ALK-IN-27 ) | 2739866-40-9 | ≧98.0% | .png) |
| NVL-655 is a novel, brain-penetrant, ALK-selective inhibitor that was designed to add | ||||
| 51803 | Semaxanib (SU5416) | 204005-46-9 | 98% | -cas-204005-46-9.png) |
| Semaxanib (SU5416) is a potent and selectiveVEGFR(Flk-1/KDR) inhibitor withIC50of 1.2 | ||||
| 1711222 | Asciminib ( ABL001 ) | 1492952-76-7 | 99.35% |  |
| Asciminib, Bulk in stock, contact us by email for the quotation. Kg scale intermediat | ||||
| 1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% |  |
| Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) targeting c-kit, platelet-d | ||||
| 20635 | ERAS-801 ( JGK-068S ) | 2490431-16-6 | ≧98.0% |  |
| ERAS-801 ( JGK-068S ) is a potent EGFR inhibitor. | ||||